Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKYX Platforms Corp. Director's Dealing 2022

Feb 14, 2022

33953_dirs_2022-02-14_02d365a7-267f-459f-aa7c-884f72e96856.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SQL Technologies Corp. (SKYX)
CIK: 0001598981
Period of Report: 2022-02-14

Reporting Person: SOKOLOW LEONARD J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-14 Common Stock, no par value J 86032 Acquired 317656 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, no par value 309667 Direct
Common Stock, no par value 3600 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.60 2025-11-15 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $3.00 2027-04-19 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $4.00 2027-04-19 Common Stock, no par value (150000) 150000 Direct
Stock Option (right to buy) $3.00 2023-01-01 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $3.00 2024-01-01 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12.00 2025-01-01 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12.00 2025-12-31 Common Stock, no par value (100000) 100000 Direct
Stock Option (right to buy) $12.00 2026-12-31 Common Stock, no par value (100000) 100000 Direct
Warrant (right to buy) $12.00 2023-12-31 Common Stock, no par value (4469) 4469 Direct
Warrant (right to buy) $12.00 2024-10-26 Common Stock, no par value (1088) 1088 Direct
Warrant (right to buy) $12.00 2024-11-29 Common Stock, no par value (3375) 3375 Direct
Warrant (right to buy) $12.00 2024-12-22 Common Stock, no par value (19827) 19827 Direct
Warrant (right to buy) $12.00 2023-12-31 Common Stock, no par value (5674) 5674 Indirect
Warrant (right to buy) $12.00 2024-10-26 Common Stock, no par value (725) 725 Indirect
Warrant (right to buy) $12.00 2024-11-29 Common Stock, no par value (2250) 2250 Indirect
Warrant (right to buy) $12.00 2024-12-22 Common Stock, no par value (13216) 13216 Indirect
Warrant (right to buy) $9.80 2024-06-30 Common Stock, no par value (214957) 214957 Indirect
Warrant (right to buy) $9.80 2024-08-31 Common Stock, no par value (16667) 16667 Indirect
6.0% Subordinated Convertible Promissory Note $15.00 2023-09-22 Common Stock, no par value () Direct

Footnotes

F1: These securities are owned by Newbridge Securities Corporation. The reporting person is the Chief Executive Officer and President of Newbridge Financial, Inc. and Chairman of Newbridge Securities Corporation, its broker dealer subsidiary.

F2: These securities are owned by Bridge Line Ventures, LLC Series ST-1 ("Bridge Line Ventures"). The reporting person is the Chief Executive Officer and President of Bridge Line Advisors, LLC, the manager of Bridge Line Ventures.

F3: Exercisable at any time on or prior to the expiration date at the holder's discretion at the initial exercise price of $12.00, subject to adjustment provisions (including certain anti-dilution provisions).

F4: Exercisable at any time on or prior to the expiration date at the holder's discretion at the adjusted exercise price of $9.80, subject to adjustment provisions (including certain anti-dilution provisions). The initial exercise price of $12.00 per share was automatically adjusted pursuant to applicable anti-dilution provisions in connection with the completion of the issuer's initial public offering.

F5: The principal amount, plus any accrued and unpaid interest, is convertible at any time on or prior to the maturity date at the holder's discretion at the conversion price of $15.00. This note was inadvertently omitted from the reporting person's Form 3.

F6: Represents the principal amount of the convertible note and excludes interest that may accrue. Interest on the note is payable annually, in cash or common stock, at the holder's discretion.

F7: The shares were issued pursuant to anti-dilution provisions set forth in the terms of the stock purchase agreements entered into between the issuer and Bridge Line Ventures between February 2021 and August 2021.